SANA

Sana Biotechnology, Inc. - Common Stock (SANA)

About Sana Biotechnology, Inc. - Common Stock (SANA)

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Details

Daily high

$2.84

Daily low

$2.59

Price at open

$2.83

52 Week High

$7.40

52 Week Low

$1.26

Market cap

588.7M

Dividend yield

0.00%

Volume

4.9M

Avg. volume

4.2M

P/E ratio

-2.95

Sana Biotechnology, Inc. - Common Stock News